Maze officer plans $908K stock sale under Rule 144
Rhea-AI Filing Summary
Maze Therapeutics, Inc. (MAZE) had a notice of proposed sale of common stock filed under Rule 144 for the account of officer Jason V. Coloma. The notice covers 34,501 shares of MAZE common stock held at UBS Financial Services Inc., with an indicated market value of $908,066.32 and 55,549,168 shares of common stock outstanding as of September 1, 2026. Recent sales over the prior three months were made by the Coloma Family Trust and The Coloma 2021 Irrevocable Trust, with multiple transactions in June, July, and August 2026.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold under Rule 144: 34,501 shares
Aggregate market value of securities to be sold: $908,066.32
Shares outstanding: 55,549,168 shares
+3 more
6 metrics
Shares to be sold under Rule 144
34,501 shares
Common stock of Maze Therapeutics, Inc. covered by the Form 144 notice
Aggregate market value of securities to be sold
$908,066.32
Value of the 34,501 Maze Therapeutics shares referenced in the notice
Shares outstanding
55,549,168 shares
Maze Therapeutics common stock outstanding as of September 1, 2026
Recent sale – Coloma Family Trust on 08/03/2026
31,908 shares for $852,983.80
Sale of Maze Therapeutics common stock by Coloma Family Trust
Recent sale – Coloma Family Trust on 07/01/2026
31,908 shares for $956,528.45
Sale of Maze Therapeutics common stock by Coloma Family Trust
Recent sale – Coloma 2021 Irrevocable Trust on 08/03/2026
2,593 shares for $69,329.00
Sale of Maze Therapeutics common stock by The Coloma 2021 Irrevocable Trust
Key Terms
Rule 144, irrevocable trust, attorney-in-fact, Form 144, +1 more
5 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
irrevocable trust financial
"The Coloma 2021 Irrevocable Trust DTD 09/20/2021"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
attorney-in-fact regulatory
"UBS Financial Services Inc., as attorney-in-fact for Jason Coloma"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
aggregate market value financial
"34501 | 908066.32 | 55549168 | 09/01/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
FAQ
What does the Form 144 filing for MAZE disclose about planned stock sales?
The Form 144 for MAZE discloses a proposed sale under Rule 144 of 34,501 shares of Maze Therapeutics common stock for the account of officer Jason V. Coloma, with the position held at UBS Financial Services Inc. and valued at $908,066.32 based on the filing.
What clarification is provided in the remarks section of the MAZE Form 144?
The remarks state that 2,593 shares for this filing were sold under The Coloma 2021 Irrevocable Trust DTD 09/20/2021 and 31,908 shares were sold under Coloma Family Trust DTD 06/27/2016, clarifying how shares relate to the respective trusts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
